Community/Retail

Ethical dilemmas do surface from time to time in the pharmacy.

At the ASHP 2017 Summer Meeting and Exhibition held in Minneapolis, Minnesota, several speakers spoke about the misuse and abuse of opioids. In this clip, Tim Stratton, PhD, BCPS, FAPhA, Professor of Pharmacy Practice at the University of Minnesota, discusses the ethical dimensions of the opioid crisis from a pharmacy practice and public health perspective.

HPV vaccination is currently indicated for the prevention of cervical, vulvar, and vaginal cancers in women, and anal cancers in both women and men.

The impact that generics have on bringing down the cost of branded drugs needs to happen in the biologics space so the industry can save money and improve access to medications and population outcomes.

Mark S. Soberman, MD, MBA, FACS, the 2017 to 2018 President of the Association of Community Cancer Centers (ACCC), discusses his vision for the next-generation of multidisciplinary care in an interview during the 2017 ASCO Annual Meeting.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Learn about the new products and expanded indications approved by the FDA in May 2017.

If you get really lucky, you might find that your company has a policy already in place that provides extra compensation for obtaining certain certifications regardless of employee performance.

Due to the increasing rise in drug abuse from opioids and recent safety warnings regarding NSAIDs, practitioners are beginning to show more interest in topical agents.

The job of a pharmacist entails way more than just counting pills.

The benefits of statins may be more far-reaching than previously thought, according to research presented at EuroCMR 2017 last week.

Is Mad Men illustrating that one cannot be creative in their daily workflow?

Cardinal Health Specialty Solutions has introduced 2017 Oncology Insights, the first in a series of research reports to provide perspective on key issues for specialty care providers, biopharma companies, and other healthcare stakeholders.

Many community pharmacists wonder what they can and should do for their patients who have HIV.

Here are some sessions to watch for in our coverage at this year’s meeting.

In 2014, the drug was granted accelerated approval to treat patients with ALK-positive NSCLC whose disease progressed on or who are intolerant to crizotinib.

Isentress has been used as a component of treatment regimens for patients diagnosed with HIV-1 for almost a decade.

Recently-published guidelines offer evidence-based recommendations for health care professionals on safely tapering or stopping proton pump inhibitors (PPIs) in patients.

The creation of novel investigational drugs that target a protein receptor found in fat tissue could pave the way for better treatments for type 2 diabetes.

The FDA today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder.

Lupin Pharmaceuticals Inc. has issued a nationwide recall of 1 lot of its oral contraceptive tablets Mibelas 24 Fe (norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate) because of out-of-sequence tablet packaging and missing expiration and lot information.

Significant changes in the delivery of health care services within the United States have given pharmacists and pharmacy technicians opportunities to advance in their roles and responsibilities.

When you are prepared, focused, and strategic, asking for what you want is easy and gets you closer to your goals.

CVS Pharmacy has announced the grand opening of its first ever standalone store in Colorado.

Ocrevus is the first medication approved for primary-progressive MS. Here's what you should know.

Apixaban Dosing in Dialysis

Congratulations on your acceptance into pharmacy school!

Active ingredients in chili peppers and cannabis help subside gut inflammation, and could lead to new therapies for diabetes and colitis.

At the Pharmacy Quality Alliance annual meeting in Baltimore, Maryland, Eleanor Perfetto, PhD, MS, Senior Vice President for Strategic Initiatives at the National Health Council, spoke with Pharmacy Times about how health systems are taking a more patient-centered approach.